2025 China Drug Catalog Boosts Access with 114 ...

By HEOR Staff Writer

December 9, 2025

Expansion of Coverage in the 2025 National Basic Medical Insurance Drug Catalog In this update we highlight updates and implications of the 2025 Nationa...
NICE Approves Seven Digital Cardiac Rehabilitation Technologies for Enhanced ...
Repurposing Off-Patent Medicines: Insights from the EU Pilot Initiative
Innovations in Haematology Cell Therapy at ASH 2025
WHO Guidelines Set New Standard for GLP-1 Obesity Therapies in Adults
Enhancing Efficiency in FAST-EU Clinical Trials: A New Era for Biomedical Res...
GLP-1RAs Psychiatric Care: Transforming Metabolic Management for Psychotropic...
NICE Endorses Obecabtagene Autoleucel Therapy for Adult Relapsed B-Cell Leuka...
Accelerating Access to Latin America Innovative Therapies Through Collaborati...
Rethinking HEOR Market Access Integration: A Call for Early Engagement Before...
Patient-Reported Outcomes Trends in Clinical Trials: Insights from 2008-2023
Addressing AI Polyp Detection Gaps: A Roadmap for Evidence Generation and NHS...
Promising Advances in TNBC Treatment: Sacituzumab Govitecan in First-Line The...